Business

CAMP4 to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that the Company will participate in the following upcoming investor conferences: Leerink Partners Global Healthcare C

articleCamp4 Therapeutics CorporationMarch 6, 20262/company/camp4-therapeutics-corporation/news/camp4-to-participate-in-upcoming-investor-conferences-2
CAMP4 to Participate in Upcoming Investor Conferences

About this update from Camp4 Therapeutics Corporation

[{"type":"image","alt":"CAMP4 Therapeutics","displaySize":"","headline":null,"caption":"CAMP4 Therapeutics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":94,"url":"https://media.zenfs.com/en/globenewswire.com/21702dc1d4660b70780cbc865b3cc20b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/FOgCfQCojUOWCCToPToW_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/21702dc1d4660b70780cbc865b3cc20b","width":300,"height":94}},"lazy":false},{"type":"text","content":"CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that the Company will participate in the following upcoming investor conferences:","length":463,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"2","style":"vertical-align:middle;","val":[{"type":"text","content":"Leerink Partners Global Healthcare Conference","length":45,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"max-width:26%;width:26%;min-width:26%;vertical-align:middle;","val":[{"type":"text","content":"Format:","length":7,"tagName":"p","attribs":{}}]},{"style":"max-width:74%;width:74%;min-width:74%;vertical-align:middle;","val":[{"type":"text","content":"Fireside Chat","length":13,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:middle;","val":[{"type":"text","content":"Date and Time:","length":14,"tagName":"p","attribs":{}}]},{"style":"vertical-align:middle;","val":[{"type":"text","content":"March 9, 2026, 8:40 a.m. ET","length":27,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:middle;","val":[{"type":"text","content":"Location:","length":9,"tagName":"p","attribs":{}}]},{"style":"vertical-align:middle;","val":[{"type":"text","content":"Miami, FL","length":9,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:middle;","val":[{"type":"text","content":"Webcast Link:","length":13,"tagName":"p","attribs":{}}]},{"style":"vertical-align:middle;","val":[{"type":"text","content":"Click Here","length":10,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical...

More updates from Camp4 Therapeutics Corporation

genetic diseasesinvestor conferencesCAMP4biopharmaceutical companygene expressionWebcast Link